Research Group Panagiotis Balermpas

Keywords

Head and Neck Cancer, Skin Cancer, Anal Cancer, Stereotactic Radiotherapy

Summary & Mission statement

Optimize interdisciplinary management and multimodality treatment of patients with head and neck, skin and anal cancer through technical innovation, clinical and translational research.

Overview

Prof. Dr. Panagiotis Balermpas, chief of service and senior consultant in the Department of Radiation Oncology, is head of the study office for clinical studies. His main focus and area of interest is optimization of multimodality treatment of head and neck, skin and anal cancer. He has published several publications in the field of translational research, exploring both the impact of viral infections and immune-microenviroment in these diseases, as well as studies about novel radiotherapy-chemotherapy/immunotherapy combinations and implementation of stereotactic radiotherapy regimens for treatment of primary and recurrent disease. His current work includes the first prsopective trial on MR-guided adaptive radiotherapy for squamous cell carcinoma of the head and neck, a planned phase III clinical trial examining the role of steraotactic radiotherapy for the same disease but in the oligometastatic setting and implementation of the novel technology of photon counting CT for radiotherapy planning. P. Balermpas participated in several guidelines, a.o. the current S3-guideline for pharyngeal cancer, S2k-guideline for basal cell carcinoma and the Swiss Guideline for malignant melanoma. He is co-chair of the SAKK head and neck group and an active member of EORTC, ESTRO, SASRO, DEGRO and the Swiss head and neck society.

Publications

Examples of cases with low and high infiltration by PD-1-positive lymphocytes in head and neck squamous cell carcinoma samples

Dosimetric comparison between weekly and single plan adapatation during a 7 week long treatment of oropharyngeal cancer and corresponding dose volume histogram